[Leukemia in Hodgkin's disease due to cancerostatic therapy?].
D000328:Adult; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced / Q000209:etiology*; D011033:Podophyllin / Q000009:adverse effects; D011344:Procarbazine / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D014747:Vinblastine / Q000009:adverse effects
D002699:Chlorambucil; D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D011033:Podophyllin
Leukämie bei Morbus Hodgkin eine Folge kanzerostatischer Therapie.